Format

Send to

Choose Destination
Cancer Biomark. 2015;15(6):861-7. doi: 10.3233/CBM-150530.

Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection.

Author information

1
Department of Urology, University of Iowa, IA, USA.
2
Department of Pathology, University of Iowa, IA, USA.
3
Myriad Genetics, University of Iowa, IA, USA.

Abstract

BACKGROUND:

The outcome of surgically resected, apparently localized, clear cell renal carcinoma (ccRCC) is uncertain.

OBJECTIVE:

To evaluate if cell cycle progression (CCP) gene expression can predict future metastasis.

METHODS:

Pathologic T2a-T3b tumors at University of Iowa were reviewed. Patients with known or suspected metastasis, lymph node involvement or who received neoadjuvant or adjuvant radiation, chemotherapy or immunotherapy were excluded. Case and control cohorts were defined as those who did or did not develop metastatic disease within 5 years. Measured levels of 31 cell cycle genes and 15 control genes from the tumor were calculated as a CCP score. Additionally, gene expression data for a separate ccRCC cohort was downloaded from The Cancer Genome Atlas (TCGA).

RESULTS:

Univariate analysis of 26 cases and 38 controls revealed that the CCP score predicted progression to metastasis (OR 2.65, p = 0.0091). In multivariate logistic regression modeling, CCP expression remained a significant independent predictor for progression (p = 0.026). The CCP score was also significantly associated with distant metastasis in the TCGA renal cancer cohort in both univariate (p = 1.0 × 10-9) and multivariate (p = 5.6 × 10-3) analysis.

CONCLUSION:

The CCP score has prognostic value in predicting metastatic progression after resection of organ-confined ccRCC.

KEYWORDS:

Clear cell renal cell carcinoma; biological markers; kidney cancer; metastasis

PMID:
26406412
DOI:
10.3233/CBM-150530
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for IOS Press
Loading ...
Support Center